EG20787A - Long acting injection suspensions and process for their preparation - Google Patents

Long acting injection suspensions and process for their preparation

Info

Publication number
EG20787A
EG20787A EG77194A EG77194A EG20787A EG 20787 A EG20787 A EG 20787A EG 77194 A EG77194 A EG 77194A EG 77194 A EG77194 A EG 77194A EG 20787 A EG20787 A EG 20787A
Authority
EG
Egypt
Prior art keywords
preparation
long acting
injection suspensions
acting injection
intrinsic
Prior art date
Application number
EG77194A
Other languages
English (en)
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Priority claimed from US08/661,017 external-priority patent/US5773032A/en
Application granted granted Critical
Publication of EG20787A publication Critical patent/EG20787A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A61K38/105—Bombesin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EG77194A 1993-12-09 1994-12-07 Long acting injection suspensions and process for their preparation EG20787A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4342092A DE4342092B4 (de) 1993-12-09 1993-12-09 Langwirkende Injektionssuspension und Verfahren zur Herstellung
US08/661,017 US5773032A (en) 1993-12-09 1996-06-10 Long-acting injection suspensions and a process for their preparation

Publications (1)

Publication Number Publication Date
EG20787A true EG20787A (en) 2000-02-29

Family

ID=25931926

Family Applications (1)

Application Number Title Priority Date Filing Date
EG77194A EG20787A (en) 1993-12-09 1994-12-07 Long acting injection suspensions and process for their preparation

Country Status (27)

Country Link
EP (1) EP0732934B1 (fi)
JP (1) JPH09509145A (fi)
CN (2) CN1136916C (fi)
AT (1) ATE310530T1 (fi)
AU (1) AU677748B2 (fi)
BR (1) BR9408272A (fi)
CZ (1) CZ291025B6 (fi)
DE (1) DE4342092B4 (fi)
DK (1) DK0732934T3 (fi)
EE (1) EE03224B1 (fi)
EG (1) EG20787A (fi)
ES (1) ES2251715T3 (fi)
FI (1) FI116121B (fi)
HK (1) HK1063746A1 (fi)
HR (1) HRP940978B1 (fi)
HU (1) HU217081B (fi)
IL (1) IL111928A (fi)
LV (1) LV11596B (fi)
NO (1) NO318984B1 (fi)
NZ (1) NZ277239A (fi)
PL (1) PL186929B1 (fi)
RO (1) RO119343B1 (fi)
RS (1) RS49511B (fi)
RU (1) RU2152222C1 (fi)
SK (2) SK284981B6 (fi)
WO (1) WO1995015767A1 (fi)
ZA (1) ZA949798B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
SI0732934T1 (sl) * 1993-12-09 2006-02-28 Zentaris Gmbh Dolgo delujoce injekcijske suspenzije LHRH analoga in postopek njihove izdelave
AU5678398A (en) * 1997-01-29 1998-08-18 Takeda Chemical Industries Ltd. Sustained-release microspheres, their production and use
DE10040700A1 (de) * 2000-08-17 2002-02-28 Asta Medica Ag Salze von biologisch aktiven Peptiden, ihre Herstellung und Verwendung
WO2002047722A1 (fr) * 2000-12-15 2002-06-20 Takeda Chemical Industries, Ltd. Compositions medicinales agoniste ou antagoniste de la gonadoliberine non peptidyl, methode de production et utilisation desdites compositions
TW200526267A (en) * 2001-06-29 2005-08-16 Takeda Chemical Industries Ltd Controlled release composition and method of producing the same
US7098305B2 (en) * 2001-09-06 2006-08-29 Ardana Bioscience Limited Sustained release of microcrystalline peptide suspensions
EP1674082A1 (de) 2004-12-22 2006-06-28 Zentaris GmbH Verfahren zur Herstellung von sterilen Suspensionen oder Lyophilisaten schwerlöslicher basischer Peptidkomplexe, diese enthaltende pharmazeutische Formulierungen sowie ihre Verwendung als Arzneimittel
CL2007003658A1 (es) 2006-12-18 2008-05-09 Takeda Pharmaceutical Composicion de liberacion sostenida que comprende un peptido; procedimiento para preparar dicha composicion; agente profilactico o terapeutico para cancer de prostata, hiperplasia prostatica, endometriosis, fibroide uterino, fibroma uterino, pubertad
RU2548753C2 (ru) 2009-11-16 2015-04-20 Ипсен Фарма С.А.С. Фармацевтические композиции лигандов рецепторов меланокортинов
CN102504018A (zh) * 2011-10-28 2012-06-20 沈阳药科大学 可持续释放的蜂毒肽帕莫酸盐及其制剂
JP6669932B2 (ja) * 2016-03-29 2020-03-18 シャンハイ・シナジー・ファーマシューティカル・サイエンシーズ・カンパニー・リミテッド ボルチオキセチンのパモ酸塩及びその結晶形
CN108969478A (zh) * 2018-08-29 2018-12-11 江南大学 一种美金刚难溶盐缓释注射剂及其制备方法
CN110003195B (zh) * 2019-05-21 2020-05-26 湖北中医药大学 鲁拉西酮晶体及其制备方法和在注射给药系统中的应用
CN112569340A (zh) * 2020-12-31 2021-03-30 苏州素仕生物科技有限公司 一种无菌布舍瑞林注射液及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3852422A (en) * 1971-06-26 1974-12-03 Serono Ist Farm Long-active gonadotropins
NZ181036A (en) * 1975-06-12 1978-12-18 A Schally Luteinising hormone releasing hormone analogues and intermediates therefor
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
FR2647677B1 (fr) * 1989-05-31 1991-09-27 Roussel Uclaf Nouvelles micro-proteines, procede de preparation et application a titre de medicaments de ces nouvelles micro-proteines
CH679207A5 (fi) * 1989-07-28 1992-01-15 Debiopharm Sa
CH683149A5 (fr) * 1991-07-22 1994-01-31 Debio Rech Pharma Sa Procédé pour la préparation de microsphères en matériau polymère biodégradable.

Also Published As

Publication number Publication date
NO961877D0 (no) 1996-05-09
PL314913A1 (en) 1996-09-30
IL111928A0 (en) 1995-03-15
FI962354A (fi) 1996-06-06
EE03224B1 (et) 1999-10-15
EP0732934B1 (en) 2005-11-23
CZ291025B6 (cs) 2002-12-11
NO961877L (no) 1996-05-09
EP0732934A1 (en) 1996-09-25
ES2251715T3 (es) 2006-05-01
AU677748B2 (en) 1997-05-01
NZ277239A (en) 1997-03-24
ZA949798B (en) 1995-08-18
DE4342092A1 (de) 1995-06-14
JPH09509145A (ja) 1997-09-16
CN1136779A (zh) 1996-11-27
PL186929B1 (pl) 2004-04-30
HU9601584D0 (en) 1996-08-28
WO1995015767A1 (en) 1995-06-15
NO318984B1 (no) 2005-05-30
FI116121B (fi) 2005-09-30
HU217081B (hu) 1999-11-29
LV11596A (lv) 1996-12-20
DK0732934T3 (da) 2006-03-27
RU2152222C1 (ru) 2000-07-10
HRP940978A2 (en) 1997-02-28
CN1136916C (zh) 2004-02-04
FI962354A0 (fi) 1996-06-06
RO119343B1 (ro) 2004-08-30
HUT75712A (en) 1997-05-28
IL111928A (en) 1999-11-30
SK284981B6 (sk) 2006-03-02
BR9408272A (pt) 1996-12-17
ATE310530T1 (de) 2005-12-15
RS49511B (sr) 2006-10-27
HRP940978B1 (en) 2006-08-31
CZ142096A3 (en) 1996-12-11
CN1248732C (zh) 2006-04-05
DE4342092B4 (de) 2007-01-11
HK1063746A1 (en) 2005-01-14
AU1219995A (en) 1995-06-27
SK284980B6 (sk) 2006-03-02
SK66796A3 (en) 1997-08-06
CN1494919A (zh) 2004-05-12
LV11596B (en) 1997-06-20
YU72194A (sh) 1997-03-07

Similar Documents

Publication Publication Date Title
EG20787A (en) Long acting injection suspensions and process for their preparation
BG101781A (en) Active substance-containing solid preparation
PL325825A1 (en) Microemulsion for use as a carrier for administering active compounds
AU8418891A (en) Novel polyamines and method for preparation thereof
CA2203033A1 (en) Compounds and compositions for delivering active agents
CA2178592A1 (en) Long-acting injection suspensions and a process for their preparation
AU6421594A (en) High release solid preparation, preparation and use thereof
GB8922026D0 (en) Novel anti-viral and cytotoxic agent
EP2016950A8 (en) Pharmaceutical composition comprising an exendin-4 peptide
CA2354034A1 (en) Compositions containing a peptide and polylactic-glycolic acid suitable for preparing subcutaneous implants with an extended release period
TW370532B (en) The use of cetrorelix and other nona and decapeptides in the preparation of a medicament for combating AIDS and for growth stimulation
HUT74270A (en) Aqueous pharmaceutical preparations of g-csf with a long shelf life and process to prepare them
WO1998017319A3 (en) Platelet substitutes and conjugation methods suitable for their preparation
MX9710206A (es) Composicion farmaceutica de amiodarone para administracion parenteral.
BG102362A (en) New derivatives of amino acids, their preparation and application
TW327602B (en) A pharmaceutical composition of an ophthalmic suspension containing difluprednate
CA2273272A1 (en) Immediate release drug delivery forms
MY119896A (en) Long-acting injection suspensions and a process for their preparation.
MY114693A (en) Substituted benzenesulfonylureas and thioureas,processes for their preparation,their use for the production of pharmaceutical preparations, and pharmaceutical preparation containing them
AU7533394A (en) Antiacid pharmaceutical composition in the form of a suspension based on sucralphate gel
MX9602103A (es) Composiciones farmaceuticas que contienen irbesartan.
MX9604539A (es) Aminoacidos modificados para la distribucion de farmaco.